• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115

Introduction to 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile (CAS No. 56304-74-6)

2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile, identified by the chemical compound code CAS No. 56304-74-6, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the pyridine derivative class, a group of molecules widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile make it a promising candidate for further investigation in drug discovery and development.

The molecular structure of this compound consists of a pyridine ring substituted with an oxo group at the 2-position and a cyano group at the 3-position, with an additional 2-pyridinyl moiety at the 6-position. This unique arrangement of functional groups contributes to its complex interactions with biological targets, making it a subject of interest for researchers exploring novel pharmacophores. The presence of both electron-withdrawing (cyano) and electron-donating (pyridinyl) groups enhances its potential as an intermediate in synthetic chemistry and as a lead compound for pharmacological studies.

In recent years, there has been a growing interest in pyridine-based compounds due to their versatility in medicinal chemistry. Pyridines are known for their ability to modulate various biological pathways, including enzyme inhibition, receptor binding, and signal transduction. The compound 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile has been studied for its potential role in inhibiting key enzymes involved in inflammatory and metabolic disorders. Preliminary studies have suggested that this compound may exhibit anti-inflammatory properties by targeting cyclooxygenase (COX) and lipoxygenase pathways, which are crucial in the regulation of inflammatory responses.

Moreover, the structural similarity of 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile to known bioactive molecules has prompted researchers to explore its derivatives as potential scaffolds for drug design. The cyano group at the 3-position provides a site for further functionalization, allowing chemists to modify the compound's pharmacological profile. This flexibility makes it an attractive candidate for structure-activity relationship (SAR) studies aimed at optimizing its biological activity.

Recent advancements in computational chemistry have also facilitated the investigation of 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile's interactions with biological targets. Molecular docking simulations have been employed to predict how this compound might bind to enzymes and receptors involved in disease pathways. These simulations have provided valuable insights into its potential mechanisms of action and have guided experimental efforts toward developing more effective derivatives.

The synthesis of 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The process typically begins with the condensation of appropriate precursors under controlled conditions, followed by functional group transformations such as cyanation and cyclization. Researchers have reported efficient synthetic routes that leverage modern catalytic systems to enhance reaction efficiency and minimize byproduct formation.

In conclusion, 2-oxo-6-(2-pyridinyl)-1,2-dihydro-3-pyridinecarbonitrile (CAS No. 56304-74-6) represents a significant area of research in pharmaceutical chemistry. Its unique structural features and potential biological activities make it a valuable compound for further exploration in drug discovery. As our understanding of molecular interactions continues to evolve, compounds like this one will play a crucial role in developing innovative therapies for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)